2025Year5Month5Day,GEHealthcare (NASDAQ:GEHC) Announced,Its Next-Generation Nuclear Medicine Imaging SystemAuroraCompared with deep learning reconstruction technologyClarify DLThrough the U.S. Food and Drug Administration (FDA）510(k)Certification.This milestone marks a dual leap forward in precision diagnosis and treatment as well as clinical efficiency within the field of nuclear medicine, offering new solutions for complex disease management.

Aurora SPECT/CTAs the world's first dual-probe intelligent nuclear medicine platform, the system achieves a leap in diagnostic efficiency through multiple technological innovations:

• 40Millimeter Crystal Detector: Compared to Traditional Hybrid Imaging SystemsCTExpanded Detector Coverage100%, significantly increasing the amount of data collected in a single scan and shortening the lesion detection time for heart, tumor, and neurodegenerative diseases.

• Intelligent Multi-Modal Imaging: Integrated Adaptive Acquisition Protocol withAIAuxiliary positioning can automatically optimize interdisciplinary application scenarios from coronary heart disease myocardial perfusion to tumor bone metastasis monitoring, improving clinical operation efficiency.40%。

• Patient-Centered Design: Low-Dose Radiation Control and Rapid Scan Workflow (Average Reduction25%Examination Duration) Effectively improves the medical visit experience, especially suitable for elderly and mobility-impaired patients.

Clarify DLDeep Learning Reconstruction Engine Focuses on Image Quality Revolution:

• SkeletonSPECTEnhanced Algorithm: A neural network model trained on millions of clinical data can reconstruct high signal-to-noise ratio images under low count rate conditions.GEInternal medical assessment shows,98%In clinical cases, the clarity of bone structures surpasses traditional methods, and the sensitivity for detecting bone metastases is enhanced.37%。

• Seamless Workflow Integration: AsAuroraNative supporting tools,Clarify DLAchieve full-process automation from raw data to diagnostic reports without additional hardware configuration, reducing manual intervention.60%。

It is worth noting that,AuroraAdopting a modular design, it can be integrated with the existing systems of medical institutions.CT、MRIEquipment achieves data interoperability, its openAPIThe interface supports deep integration with the electronic medical record system.This feature will significantly lower the threshold for grassroots hospitals to deploy advanced nuclear medicine services, promoting the penetration of precision medical resources into the community level.

GEPresident of Medical Molecular Imaging DivisionJean-Luc ProcacciniPoints out:“The current healthcare system is facing the dual challenges of an aging population and a surge in chronic diseases. There is an urgent clinical need for innovative technologies that can both capture early disease markers and be quickly integrated into existing diagnostic and treatment pathways.AuroraAndClarify DLThe combination is precisely the solution born to resolve this contradiction.”

The system has completed prospective validation at multiple top medical centers:

• Pilot data from the Mayo Clinic shows that usingAuroraThe diagnostic coincidence rate of bone scanning for prostate cancer92.3%, an improvement over the single-photon system18Percentage points;

• MDFeedback from Anderson Cancer Center,Clarify DLReduce the generation time of bone metastasis assessment reports from72Minutes compressed to29Minutes, significantly shortening the waiting period for multidisciplinary consultations in oncology.

“This is not only a technological iteration, but also a transformation of nuclear medicine from‘High-End Specialty’To‘Inclusive Platform’The starting point of transformation.”ProcacciniEmphasis. As the two products enter the commercialization stage,GEMedical Plan Investment in the Next Three Years1.2Billion USD, establishing coverage for device operation,AIA global training network for algorithm training and clinical interpretation, helping medical institutions unleash the full potential of precision medicine.

In the wave of deep integration between precision medicine and artificial intelligence,GEGE HealthcareAuroraAndClarify DLThe collaborative innovation has set a new benchmark for efficiency and quality in the field of nuclear medicine. As this solution is promoted globally, more patients will benefit from early and precise disease diagnosis, and healthcare systems will also find a key breakthrough for optimizing resource allocation.